Biomarkers—measurable physical signs of a condition—could be a useful way of testing for Alzheimer’s disease, according to a new review study.
The study, by researchers with the Minneapolis VA Health Care System and University of Minnesota, appears in the April 28, 2020, issue of Annals of Internal Medicine, along with two other reviews on Alzheimer’s disease diagnosis and treatment.
Lead study author Dr. Howard Fink explains that accurate testing would help in…
